NovaBridge Biosciences (NBP) Work In Process (2020 - 2022)

NovaBridge Biosciences (NBP) has reported Work In Process for 3 consecutive years, with $43.5 million the latest figure, recorded in Q2 2022.

• In Q2 2022, Work In Process changed N/A year-over-year to $43.5 million; the TTM figure through Jun 2022 stood at $43.5 million (changed N/A YoY), while the FY2021 annual figure was $39.8 million, up 14.28% from the prior year.
• Work In Process rose to $43.5 million in Q2 2022 per NBP's latest filing, from $39.7 million in the prior quarter.
• Across five years, Work In Process topped out at $43.5 million in Q2 2022 and bottomed at $34.3 million in Q4 2020.
• Historically, Work In Process has averaged $39.2 million across 3 years, with a median of $39.7 million in 2021.
• On a YoY basis, Work In Process climbed as much as 15.69% in 2021 and fell as far as 15.69% in 2021.
• NovaBridge Biosciences' Work In Process stood at $34.3 million in 2020, then increased by 15.69% to $39.7 million in 2021, then rose by 9.48% to $43.5 million in 2022.
• Business Quant data shows NBP's Work In Process at $43.5 million in Q2 2022, $39.7 million in Q4 2021, and $34.3 million in Q4 2020.